News
CPEAR’s poll is a thinly veiled attempt to persuade policymakers to take a broadly popular issue in a less popular direction.
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...
4d
Worcester Telegram on MSNNicotine pouches: concerns in Mass. about potential health harms. Here are the detailsSwedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's authorization noted the pouches ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits ...
All the latest breaking news on Food and Drug Administration. Browse Newsweek archives of photos, videos and articles on Food and Drug Administration.
3d
Axios on MSNZyn nicotine pouches: America's new addictive obsessionAxios Visuals It's not food, it's not chewing tobacco and it's not gum — though it might look like it when you see it — but it is becoming America's new addictive obsession. Why it matters: Sales of ...
Altria's dominant U.S. market share, strong pricing power, and brand loyalty provide a robust moat despite declining ...
Tobacco giant Altria Group is launching a plan to streamline and modernize operations that will involve an unspecified number of layoffs, the Henrico County-based Fortune 500 company disclosed.
The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...
Buc-ee's first Virginia location has opened off Interstate 81 in Rockingham County, boasting 120 fuel pumps, souvenirs and ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results